期刊文献+

利拉鲁肽对胰岛素抵抗大鼠肾脏NF-κB及炎症因子表达的影响 被引量:7

Effects of liraglutide on the expression of NF kappa-B and inflammatory factor in kidney of insulin resistance rats
下载PDF
导出
摘要 目的:探讨利拉鲁肽对胰岛素抵抗大鼠肾组织NF-κB、TNF-α和IL-6表达的影响。方法:将大鼠随机分为4组,对照组(C)、高脂组(H)、利拉鲁肽干预低剂量组[Li-1:100μg/(kg·d)]、利拉鲁肽干预高剂量组[Li-2:200μg/(kg·d)]。用自动生化分析仪检测血肌酐、尿素氮,免疫比浊法测定24 h尿微量白蛋白,用Elisa法测定血清NF-κB、TNF-α及IL-6蛋白的浓度,用RT-PCR法测定肾组织NF-κB、TNF-α及IL-6m RNA的表达。结果 :与对照组相比,高脂组血肌酐、尿素氮、尿蛋白、血清及肾组织NF-κB、TNF-α及IL-6表达均明显升高(P<0.05),电镜可见肾小球基底膜增厚,足突融合;利拉鲁肽高剂量干预可明显减轻这些变化。结论:利拉鲁肽可呈浓度依赖性抑制高脂诱导的胰岛素抵抗大鼠肾脏NF-κB、TNF-α和IL-6的表达,可能参与肾功能改善。 Objective To investigate the effect of liraglutide on the expression of NF-kappa B(NF-KB), tumor necrosis factor-alpha(TNF-ct) and interleukin-6(IL-6) in renal tissue of insulin resistance rats. Method The rats were divided into 4 groups, control group , high fat group , liraglutide low dose group [ 100μg/(kg·d) ], liraglutide high dose group[ 100μg/(kg·d)]. Detection of serum creatinine and urea nitrogen by automatic biochemical analyzer, and 24 h urine micro albumin was determined by immunoassay. The protein concentration of serum NF-KB,TNF-ct and IL-6 was measured by ELISA. The expression of NF-κB,TNF-ct and IL-6 mRNA in renal tissues was determined by RT-PCR. Results Compared with the control group, the serum creatinine, blood urea nitrogen, urinary protein, and the expression of NF-κB, TNF-ct and IL-6 were significantly higher in high fat group, respectively (P 〈 0.05). The glomerular basement membrance thickening and foot process fusion were seen under electron microscope. Liraglutide high dose intervention can significantly reduce these changes. Conclusions Liraglutide can inhibit the expression of NF-κB,TNF-α and IL-6 in renal tissues of high fat induced insulin resistance rats,in a concentration dependent manner, which possibly improve renal function.
作者 吴晓静 胡桂才 高宇 吴明昊 刘剑 WU Xiao-jing HU Gui-cai GAO Yu WU Ming-hao LIU Jiau(Graduate School of Chengde Medical College, Chengde 067000, Chin)
出处 《实用医学杂志》 CAS 北大核心 2016年第18期3000-3003,共4页 The Journal of Practical Medicine
关键词 胰岛素抵抗 利拉鲁肽 核因子-ΚB 肿瘤坏死因子-α 白细胞介素-6 Insulin resistance Liraglutide Nuclear factor-kappa B tumor necrosis factor-alpha lnterleukin-6
  • 相关文献

参考文献14

  • 1舒毅,陈幼萍,曾春平,潘苗,罗少莊.罗格列酮对早期糖尿病肾病脂联素的影响[J].实用医学杂志,2011,27(11):2024-2026. 被引量:6
  • 2KUMAR R, YONG QC, THOMAS CM. Domultiplenuclear factor kappa B activation mechanisms explainits varied effects in the heart [J] .Ochsner J,2013,13( 1 ) : 157-165.
  • 3OJIMA A, ISHIBASHI Y, MATSUI T, et al. Glucagon-like peptide-I receptor agonist inhibits as asymmetric dimethy larginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-in duced protein arginine methyltranferase-1 expression [J]. Am J Pathol, 2013,182( 1 ) : 132-141.
  • 4李里,卢松.利拉鲁肽对糖尿病大鼠肾脏病变的影响[J].中国药业,2014,23(14):20-22. 被引量:4
  • 5万青松,谢红萍,杨波,欧继红.阿托伐他汀钙对2型糖尿病肾病患者瘦素的影响[J].实用医学杂志,2014,30(22):3655-3657. 被引量:5
  • 6FESTA A, DAQOSTINO R, HOWARD G, et al. Chronic subcIinicl in flammation as part of the insulin resistance syndrome :the Insulin Resistance Athe rosclerosis Study (IRAS) [J]. Circulation, 2000: 102( 1 ) :42-47.
  • 7VASANTHAKUMAR R, MOHAN V, ANAND C, et al. Serum IL-9,1L-17,and TGF-beta levels in subjects with diabetic kidney disease [ J ]. Cytokine, 2015,72 ( 1 ) : 109-112.
  • 8王爱霞.阿托伐他汀联合阿魏酸钠治疗糖尿病肾病的疗效及对肾间质纤维化指标的影响[J].中国现代医学杂志,2015,25(1):98-101. 被引量:33
  • 9闫双通,李春霖,陆菊明,等.NF-kB及下游炎症因子在胰岛素抵抗大鼠心肌中的表达及意义[J].医学临床研究,2015,22(2):359-362.
  • 10RYU S, SHIN JS, JUNG JY, et al. Echinocystic acid isolated from eclipta prostrata suppresses lipopolysaeeharide-induced iNOS, TNF-, and IL-6 expression via NF-KB inactivation in RAW 264.7 macrophages [J]. P lanta Med,2013,79 (12) : 1031-1037.

二级参考文献36

  • 1李惠清,于海英.阿托伐他汀联合阿魏酸钠治疗糖尿病肾病肾间质纤维化的临床研究[J].中国生化药物杂志,2014,34(4):120-122. 被引量:16
  • 2Ran J, Xiong X, Liu W, et al. Increased plasma adiponectin closely associates with vascular endothelial dysfunction in type 2 diabetic patients with diabetic nephropathy [J]. Diabetes Res Clin Parct, 2010,88(2) : 177-183.
  • 3Sarafidis P A, Stafylas P C, Georgianos P I, et al. Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis [ J ]. Am J Kidney Dis, 2010,55 (5) : 835-847.
  • 4Miyazaki Y, Cersosimo E, Triplitt C, et al. Rosiglitazone decreases albuminuria in type 2 diabetic patients [J]. Kidney Int, 2007,72( 11 ) : 1367-1373.
  • 5Bao Y, Jia R H, Yuan J, et al. Rosiglitazone ameliorates diabetic nephropathy by inhibiting reactive oxygen species and its downstream-signaling pathways [J]. 2007,80( 1 ) : 57-64.
  • 6Shiraki N, Lai C J, Hishikari Y, et al. TGF2B signaling potentiates differentiation of embryonic stem cells to Pdx-1 expressing endodermal cells [J]. Gene Cells, 2005,10(6) : 503- 516.
  • 7Yuan H, Liu H, Tian R, et al. Regulation of mesenchymal stem cell differentiation and insulin secretion by differential expression of Pdx- 1 [ J ]. Mol Biol Rep, 2012,39 ( 7 ) : 7777-7783.
  • 8Drueker DJ, Nauek MA. The incretin system:glucagon-like peptide-1 recepter agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J]. Lancet, 2006,368(9548) : 1696-1705.
  • 9Yang M, Zhang L, Wang C, et al. Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance [J]. PLoS ONE, 2012,7 ( 11 ) : e48392.
  • 10Chiquette E, Toth PP , Ramirez G, et al. Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers [J]. Vasc Health Risk Manag, 2012,8 : 621-629.

共引文献59

同被引文献59

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部